We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.31%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$484B
AUM Growth
+$13.2B
Cap. Flow
-$3.88B
Cap. Flow %
-0.8%
Top 10 Hldgs %
13.39%
Holding
2,630
New
93
Increased
1,078
Reduced
887
Closed
93

Sector Composition

Rank Sector Weight
1 Healthcare 21.05%
2 Consumer Discretionary 13.82%
3 Financials 13.14%
4 Industrials 11.9%
5 Technology 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LBRDA icon
1901
Liberty Broadband Class A
LBRDA
$5.26B
$596K ﹤0.01%
10,555
-120
-1% -$6.09K
EWA icon
1902
iShares MSCI Australia ETF
EWA
$1.45B
$594K ﹤0.01%
26,000
+8,100
+45% +$185K
NBTB icon
1903
NBT Bancorp
NBTB
$2.78B
$591K ﹤0.01%
23,580
ZAYO
1904
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$590K ﹤0.01%
21,100
-2,600
-11% -$74.1K
OLED icon
1905
Universal Display
OLED
$4.21B
$589K ﹤0.01%
12,600
SFR
1906
DELISTED
Starwood Waypoint Homes
SFR
$589K ﹤0.01%
22,800
+6,200
+37% +$157K
GATX icon
1907
GATX Corp
GATX
$6.33B
$588K ﹤0.01%
10,150
STBA icon
1908
S&T Bancorp
STBA
$1.81B
$587K ﹤0.01%
20,700
IART icon
1909
Integra LifeSciences
IART
$1.42B
$586K ﹤0.01%
23,241
-734
-3% -$17.4K
UFCS icon
1910
United Fire Group
UFCS
$1.38B
$585K ﹤0.01%
18,400
-600
-3% -$17.6K
NUVA
1911
DELISTED
NuVasive, Inc.
NUVA
$584K ﹤0.01%
12,700
RPT
1912
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$582K ﹤0.01%
31,296
+602
+2% +$11.5K
FMBI
1913
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$575K ﹤0.01%
33,093
CAB
1914
DELISTED
Cabela's Inc
CAB
$573K ﹤0.01%
10,241
PVTB
1915
DELISTED
PrivateBancorp Inc
PVTB
$568K ﹤0.01%
16,160
CYS
1916
DELISTED
CYS Investments Inc.
CYS
$567K ﹤0.01%
63,687
-15,359
-19% -$137K
ENS icon
1917
EnerSys
ENS
$7.19B
$565K ﹤0.01%
8,800
NWN icon
1918
Northwest Natural Holdings
NWN
$2.13B
$565K ﹤0.01%
11,790
-1,000
-8% -$48.4K
TM icon
1919
Toyota
TM
$223B
$565K ﹤0.01%
4,037
TTEK icon
1920
Tetra Tech
TTEK
$9.28B
$561K ﹤0.01%
116,875
NHI icon
1921
National Health Investors
NHI
$3.51B
$560K ﹤0.01%
7,890
+1,100
+16% +$79.4K
LTC
1922
LTC Properties
LTC
$2.1B
$559K ﹤0.01%
12,150
+3,400
+39% +$154K
B
1923
DELISTED
Barnes Group Inc.
B
$559K ﹤0.01%
13,800
FFBC icon
1924
First Financial Bancorp
FFBC
$3.59B
$555K ﹤0.01%
31,142
AMD icon
1925
Advanced Micro Devices
AMD
$795B
$554K ﹤0.01%
206,672
+4,407
+2% +$12.4K

Similar funds

T. Rowe Price Associates's Q1 2015 Portfolio in Review

As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
  • T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
  • T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
  • T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
  • T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
  • T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
  • T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.

Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.